Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
B220/CD45R Antibody (YKIX753.22.2) - BSA Free, Novus Biologicals™
Rat Monoclonal Antibody
Supplier: Novus Biologicals NB100650180.1MG
Description
B220/CD45R Monoclonal specifically detects B220/CD45R in Canine samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Frozen.Specifications
B220/CD45R | |
Monoclonal | |
1.0 mg/mL | |
Flow Cytometry 1:50-1:100, Immunohistochemistry 1:10-1:500, Immunoprecipitation 1:10-1:500, Immunohistochemistry-Frozen 1:10-1:500 | |
B220, CD45 antigen, CD45R, EC 3.1.3.48, L-CA, LY5, protein tyrosine phosphatase, receptor type, C, receptor-type tyrosine-protein phosphatase C, T200 glycoprotein, T200 leukocyte common antigen, T200receptor type, c polypeptide | |
Rat | |
Protein G purified | |
Hematopoietic Stem Cell Markers, Immunology, Mesenchymal Stem Cell Markers, Microglia Markers, Stem Cell Markers | |
5788 | |
Canine | |
Purified |
Flow Cytometry, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry (Frozen) | |
YKIX753.22.2 | |
Unconjugated | |
Phosphate buffered saline with 0.09% Sodium Azide | |
PTPRC | |
Canine thymocytes | |
0.1 mg | |
Primary | |
This antibody recognizes canine CD45R and was clustered as a canine CD45R at the first canine Leucocyte Antigen workshop. It precipitates an antigen of 220kD from Con A Blasts (1) and may be against a CD45R isoform. It is expressed on subsets of leucocytes (neutrophils are weak) in canine blood of all out bred mongrels and beagles tested. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG2b |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?
Provide Content Correction